Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Dan Atlan"'
Autor:
Timothy Price, Chiara Cremolini, Alfredo Falcone, Eric Van Cutsem, Julien Taieb, Jean-Marc Phelip, Jean-Baptiste Bachet, Lucjan Wyrwicz, Fabienne Portales, Ahmet Ozet, Irfan Cicin, Dan Atlan, Martin Becquart, Loick Vidot, Nadjat Mounedji
Publikováno v:
ESMO Open, Vol 5, Iss 3 (2020)
Externí odkaz:
https://doaj.org/article/f278b869784d4e0e9c442dc4a12a9eff
Autor:
Timothy Price, Chiara Cremolini, Alfredo Falcone, Eric Van Cutsem, Julien Taieb, Jean-Marc Phelip, Jean-Baptiste Bachet, Lucjan Wyrwicz, Fabienne Portales, Ahmet Ozet, Irfan Cicin, Dan Atlan, Martin Becquart, Loick Vidot, Nadjat Mounedji
Publikováno v:
ESMO Open, Vol 5, Iss 3 (2020)
Background In RECOURSE (, trifluridine/tipiracil significantly improved overall survival and progression-free survival (PFS) versus placebo in patients with pretreated metastatic colorectal cancer (mCRC). PRECONNECT was designed to further characteri
Externí odkaz:
https://doaj.org/article/d4363a641e6c4b95ba550f4e125c6b83
Autor:
Loick Vidot, Julien Taieb, Irfan Cicin, Ahmet Ozet, Martin Becquart, Fabienne Portales, Timothy J. Price, Chiara Cremolini, Dan Atlan, Jean-Marc Phelip, Jean-Baptiste Bachet, Nadjat Mounedji, Eric Van Cutsem, Alfredo Falcone, Lucjan Wyrwicz
Publikováno v:
Open
Open, 2020, 5 (3), pp.e000698. ⟨10.1136/esmoopen-2020-000698⟩
ESMO Open
Open, J. Wiltenburg, 2020, 5 (3), pp.e000698. ⟨10.1136/esmoopen-2020-000698⟩
ESMO Open, Vol 5, Iss 3 (2020)
Open, 2020, 5 (3), pp.e000698. ⟨10.1136/esmoopen-2020-000698⟩
ESMO Open
Open, J. Wiltenburg, 2020, 5 (3), pp.e000698. ⟨10.1136/esmoopen-2020-000698⟩
ESMO Open, Vol 5, Iss 3 (2020)
BACKGROUND: In RECOURSE (, trifluridine/tipiracil significantly improved overall survival and progression-free survival (PFS) versus placebo in patients with pretreated metastatic colorectal cancer (mCRC). PRECONNECT was designed to further character
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aa2d1c5f07241302eb7c6faa34b0d96
https://lirias.kuleuven.be/handle/123456789/655767
https://lirias.kuleuven.be/handle/123456789/655767
Autor:
Pauline Ries, Philippe Rougier, Emmanuel Mitry, Tandat Nguyen, Jean-François Seitz, Gérard Lledo, Pascal Artru, Olivier Bouché, Karine Richard, Dan Atlan, Laetitia Dahan
Publikováno v:
Gastroentérologie Clinique et Biologique. 29:11-15
Summary Aim of the study A North American phase III trial has recently shown that postoperative chemoradiotherapy using the FUFOL Mayo Clinic regimen improves overall survival and relapse-free survival after surgical resection of gastric cancer. Howe
Publikováno v:
European Journal of Internal Medicine. 13:227-232
HIV-infected patients are at an increased risk for developing cancers. Three, in particular, are considered to be AIDS-defining malignancies: Kaposi's sarcoma (KS), non-Hodgkin's lymphoma (NHL), and cervical cancer. Other non-AIDS-defining malignanci
Autor:
Michel Schlienger, Jean-Jacques Merland, Catherine Oppenheim, Emmanuel Touboul, L. Merienne, Hammid Mammar, François Nataf, J.N. Foulquier, Jean-François Meder, Pascal Grandjean, J. Huart, Dan Atlan, Kaliopi Platoni, Dimitrios Lefkopoulos, Emmanuel Houdart, O. Missir
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 46:1135-1142
Purpose: To present the SALT group results using Linac radiosurgery (RS) for AVM in 169 evaluable patients treated from January 1990 thru December 1993. Methods and Materials: Median age was 33 years (range 6–68 years). Irradiation was the only tre
Autor:
Laetitia, Dahan, Dan, Atlan, Olivier, Bouché, Emmanuel, Mitry, Pauline, Ries, Pascal, Artru, Karine, Richard, Gérard, Lledo, Tandat, Nguyen, Philippe, Rougier, Jean-François, Seitz
Publikováno v:
Gastroenterologie clinique et biologique. 29(1)
A North American phase III trial has recently shown that postoperative chemoradiotherapy using the FUFOL Mayo Clinic regimen improves overall survival and relapse-free survival after surgical resection of gastric cancer. However, severe grade 3-4, he
Autor:
Michele Uzan, Catherine Genestie, Dan Atlan, Serge Uzan, Jean-Pierre Lefranc, D. Jannet, Myriam Jamali, Pierre Lhuillier, Jacques Milliez, Elisabeth Deniaud-Alexandre, Martine Antoine, Judith Huart, Jean-Marie Antoine, Jean Blondon, Emmanuel Touboul, Valerie Ganansia
Publikováno v:
International journal of radiation oncology, biology, physics. 54(3)
Purpose: To evaluate our data concerning prognostic factors and treatment toxicity in a series of operable cervical carcinomas. Methods and Materials: Between May 1972 and January 1994, 414 patients with cervical carcinoma, staged according to the 19
Autor:
G. Bodoky, Michael Borre, Daniel Castellano, O. Capoun, I. Skoneczna, Dan Atlan, Marcello Tucci, G. Fountzilas, G. Kacso, Tracy McGowan, Cora N. Sternberg, V. Naini, E. Lee, Betty Goon, Sergio Bracarda, Arturo Molina, Anil Londhe, P. De Porre, Vsevolod Matveev
Publikováno v:
Annals of Oncology. 25:iv269
Aim: Following release of COU-AA-301 pivotal trial data, a global early access protocol (EAP) was opened to enable preapproval access to abiraterone acetate (AA) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) who had progr
Autor:
Arturo Molina, Paul N. Mainwaring, Luca Galli, Dan Atlan, Betty Goon, Peter De Porre, Ciro Souza, V. Naini, Fred Saad, Jose Manuel Garrido, Gedske Daugaard, Anil Londhe, Lajos Géczi, Daniel J. George, Sebastien J. Hotte, Cora N. Sternberg, Mary B. Todd, Emma Lee, Tracy McGowan, Miah Hiang Tay
Publikováno v:
Journal of Clinical Oncology. 32:5061-5061
5061 Background: A global EAP was conducted to provide broader access to pts with mCRPC post-chemotherapy and to generate additional clinical efficacy and safety data for AA after registrational st...